UBS Oncology Impact Fund L.P. 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-19 4:33 pm Purchase | 2021-01-12 | 13D | Cullinan Oncology, Inc. CGEM | UBS Oncology Impact Fund L.P. | 8,546,093 19.600% | 8,546,093 (New Position) | Filing |